SPRC
SPRC
NASDAQ · Pharmaceuticals

Scisparc Ltd

$4.25
-0.10 (-2.30%)
As of Mar 25, 6:05 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.79M
Net Income
-13,432,845
Gross Margin
38.7%
Profit Margin
-480.9%
Rev Growth
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.7% 57.0% 57.0% 57.0%
Operating Margin -560.5% 38.0% 34.2% 35.2%
Profit Margin -480.9% 28.8% 31.3% 33.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.79M 1.37M 1.35M 1.33M
Gross Profit 1.08M 780.7K 772.6K 759.7K
Operating Income -15,657,417 520.1K 463.6K 468.3K
Net Income -13,432,845 393.8K 424.2K 446.9K
Gross Margin 38.7% 57.0% 57.0% 57.0%
Operating Margin -560.5% 38.0% 34.2% 35.2%
Profit Margin -480.9% 28.8% 31.3% 33.6%
Rev Growth -0.9% -3.8% +21.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 8.0K 742.2K 970.1K 740.6K
Total Equity 1.31M 898.9K 893.1K 867.5K
D/E Ratio 0.01 0.83 1.09 0.85
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -14,630,677 809.4K 830.6K 717.6K
Free Cash Flow 304.8K 355.4K 299.5K